Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
CJC-1295 / Ipamorelin What It Is: A synthetic growth-hormone-releasing peptide stack combining CJC-1295, a modified growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective ghrelin-receptor agonist (growth hormone secretagogue)
Medicare covers this code when: The drug administered is not a self-administered medication (Medicare excludes most self-administered drugs from Part B coverage) The injection is not a vaccine (use the 90471 series for vaccine administration) The physician or qualified clinical staff administers the injection under direct supervision The medical record links the injection to a covered ICD-10 diagnosis code that supports medical necessity The drug J-code and NDC are reported on the same claim as 96372 Even when all five conditions are met, specific claim errors still trigger denial
[Accessed on 4th November 2022] 6
Every KLOW vial is independently verified through third-party laboratory testing for identity, purity, and concentration, and ships with a Analytical Data Sheet (ADS) and a unique authentication code
JACS Au 2(9):20682080
The specific protocol depends on the condition being treated and individual patient factors
US$ 20.79
US$ 29.97
US$ 23.82
US$ 21.88
